The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here is how Figure Technology (FIGR) and Hackett Group (HCKT) have performed compared to their sector so far this year.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares moved higher in early trade on Monday as it reported positive topline three-year results from its Phase 3 EMBARK study evaluating its gene therapy ELEVIDYS in ambulatory patients with Duchenne muscular dystrophy. Sarepta said patients treated with ELEVIDYS demonstrated statistically significant and clinically meaningful slowing of disease progression across key functional measures compared with an untreated external control group.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here is how FedEx (FDX) and LATAM (LTM) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

LOS ANGELES, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SLM Corporation a/k/a Sallie Mae (“SLM” or “the Company”) (NASDAQ: SLM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 25, 2025 and August 14, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before February 17, 2026.

IonQ Inc (NYSE:IONQ) shares are up 6% to trade at $50.08 at last glance, after the quantum computing giant announced it will acquire semiconductor maker SkyWater Technology (SKYT) in a deal valued at $1.8 billion.

Bausch (BHC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

The heavy selling pressure might have exhausted for GoDaddy (GDDY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Tarsus Pharmaceuticals (TARS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Lands' End ( NASDAQ:LE ) stock jumped over 33% in early trading this morning after the company announced a joint venture with WHP Global to monetize its intellectual property.

Netflix is upgraded to a strong buy after a steep sell-off and pending Warner Bros. Discovery acquisition. NFLX delivered double-digit revenue growth, solid ad performance, and expanding margins, despite short-term volatility and slowing growth projections. I expect the WBD acquisition to close, enhancing content and subscriber growth, though regulatory approval remains a risk.

NDAQ's Q4 results are likely to reflect higher subscription revenues, new listings, higher trade management services business and new client contracts.

HAL plans a swift Venezuela restart pending U.S. approval and payment safeguards, aiming to offset weak U.S. shale demand and fuel Latin America growth.